Showing results (201-210 of 213) with videos related to
Sort By:
Pageof 22
Annals of Family Medicine|July 13, 2016
Improving the Diagnosis and Treatment of Urinary Tract Infection in Young Children in Primary Care: Results from the DUTY Prospective Diagnostic Cohort StudyAlastair D Hay, Jonathan A C Sterne, Kerenza Hood, et al.Antibiotics (Basel, Switzerland)|June 2, 2021
Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational StudyNeil Powell, Philip Howard, Martin J Llewelyn, et al.The Lancet. Respiratory Medicine|March 25, 2026
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trialStacy Todd, Joanne Euden, Jennifer Condie, et al.Human Mutation|December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practiceGillian Ellison, Miika Ahdesmäki, Sally Luke, et al.The Journal of Antimicrobial Chemotherapy|June 6, 2024
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH studyEdward J D Webb, Daniel Howdon, Rebecca Bestwick, et al.BMJ Open|August 8, 2025
Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sourcesJosie Henley, Lucy Brookes-Howell, Philip Howard, et al.Journal of Medicinal Chemistry|January 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate CancerJames S Scott, Laura Evans, Peter C Astles, et al.The Journal of Antimicrobial Chemotherapy|September 9, 2024
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19Jonathan A T Sandoe, Detelina Grozeva, Mahableshwar Albur, et al.Cancer Discovery|September 1, 2018
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical TrialKhurum H Khan, David Cunningham, Benjamin Werner, et al.Health Technology Assessment (Winchester, England)|November 11, 2025
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods studyJoanne Euden, Mahableshwar Albur, Rebecca Bestwick, et al.Pageof 22